The city of Fort Myers, Florida, currently has 13 active clinical trials seeking participants for Breast Cancer research studies.
A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer
Recruiting
This study is to evaluate safety and efficacy of an antibody drug conjugate U3-1402 (patritumab deruxtecan) in patients with locally advanced or metastatic breast cancer (MBC).
Gender:
All
Ages:
18 years and above
Trial Updated:
01/22/2024
Locations: Florida Cancer Specialists-South, Fort Myers, Florida
Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer